Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

USPSTF Recommendations For Colon Cancer Screening At Age 45 Could Give Cologuard A Boost

Nov 05 2020

• By Marion Webb

Colorectal cancer; medical anatomical illustration

Related Content

Exact Launches Real-World Trial Of Cologuard Colon Cancer Screening

Oct 23 2019

Exact Goes All-In On Multi-Cancer Screening With $2.15Bn For Thrive; $410M For Base Genomics

Oct 28 2020

Related Companies

Exact Sciences Corp.

Pfizer Inc.

Thrive Earlier Detection Corp.

Base Genomics

Additional Topics

Policy Business Strategies Coronavirus COVID-19 Reimbursement Telehealth Commercial Cancer Diagnostics In Vitro Diagnostics Medical Device

More from Oncology

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window